A study published in the Annals of Surgical Oncology Journal has shown that implementation of a multidisciplinary surgical team (MDT), using a meticulous approach for ensuring a patient is in optimum clinical condition prior to surgery, results in significantly improved rates of complete resection of ovarian cancer. An MDT comprises gynaecologic oncologists and colorectal, hepatobiliary and upper gastrointestinal (GI) surgeons.
This approach to aggressive surgery for ovarian cancer is based on the fact that ovarian cancer often presents with widespread disease throughout the abdomen and surgery can often involve removal of multiple organs and the entire inner lining of the abdominal cavity.
Speaking about this approach to completely resecting ovarian cancer, Professor Donal Brennan, UCD Professor of Gynaecological Oncology and Consultant Obstetrician and Gynaecological Oncologist at the Mater and St Vincent’s University Hospitals explained: "Surgical resection remains the cornerstone of ovarian cancer management. The goal of surgery in ovarian cancer is to remove all visible disease and this can involve extensive resections including hysterectomy, removal of the ovaries, rectum (and other parts of the bowel), spleen, gallbladder and stripping or resection of the diaphragm. Since 2017, in the UCD Gynaecological Oncology Group based at the Mater and St Vincent’s University Hospitals, we identify the right specialist surgeon to conduct each part of the resection making it a much more sustainable and safer approach to surgery."
The study examined two cohorts of patients:
The results of the study showed that:
Also speaking about this study, Associate Dean for Research, Innovation and Impact at UCD School of Medicine, Professor Peter Doran said: "This study published in the Annals of Surgical Oncology showed that a MDT approach has resulted in a high rate of both optimal and complete cytoreduction, with a relatively stable morbidity rate during a three-year period. The complete resection rates reported in Cohort B were significantly higher than those reported in the current literature, supporting a multidisciplinary, collaborative surgical approach to advanced ovarian cancer. This reflects the close attention paid within the MDT to ensure correct patient selection, perioperative optimization, and experienced anesthetists and surgeons in a centralized, high-volume, specialized oncology centre."
The UCD Gynaecological Oncology Group (UCD-GOG), incorporating UCD, the Mater Misericordiae University Hospital (MMUH) and St Vincent’s University Hospital, is the largest gynaecological oncology group in the country serving over two million people. The group offers specialist treatment for all types of gynaecological cancers including advanced surgery, radiotherapy and chemotherapy. UCD-GOG receives 500 new referrals per year from across the country and treats nearly 400 new cancers annually.
UCGOG aims to deliver a high quality, evidence based, continuously improving, person centred service, utilising a comprehensive inter disciplinary approach to achieve best patient outcomes, informed by evidence based clinical care. The UCD-GOG service also aims to be compassionate and caring whilst also being transparent and efficient from point of referral through to survivorship.